New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
Taiwan News2d
HIV Drugs Market Poised for Steady Growth, Valued at USD 34.28 Billion in 2023 with a Projected 4.5% CAGR Through 2032
Global HIV Drugs Market is valued at approximately USD 34.28 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2024-2032. Read the Market ...
GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology
GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...